The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Consumer Healthcare Drug Market Research Report 2024
Synopsis
Consumer health products are products sold directly to consumers. Unlike prescription drugs, selection and use of consumer health products does not require the oversight of a health care practitioner.
Global Consumer Healthcare Drug market is projected to reach US$ 182520 million in 2029, increasing from US$ 125150 million in 2022, with the CAGR of 5.5% during the period of 2023 to 2029. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Consumer Healthcare Drug market research.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2029), aims to help readers to get a comprehensive understanding of global Consumer Healthcare Drug market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
By Company
Johnson & Johnson
AbbVie
Merck & Co.
GlaxoSmithKline
Pfizer
Sanofi
Takeda
Bayer
Teva
Sinopharm Group
CR Pharmaceutical
Shanghai Pharmaceuticals
Hualan Bio
North China Pharmaceutical
Hengrui Medicine
Fosun Pharma
East China Medicine
Livzon Group
Segment by Type
Solid Preparations
Oral Liquid
Patch
Other
Segment by Application
Hospital
Retail Pharmacy
Other
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
The Consumer Healthcare Drug report covers below items:
Chapter 1: Product Basic Information (Definition, Type and Application)
Chapter 2: Global market size, regional market size. Market Opportunities and Challenges
Chapter 3: Companies’ Competition Patterns
Chapter 4: Product Type Analysis
Chapter 5: Product Application Analysis
Chapter 6 to 10: Country Level Value Analysis
Chapter 11: Companies' Outline
Chapter 12: Market Conclusions
Chapter 13: Research Methodology and Data Source
Consumer health products are products sold directly to consumers. Unlike prescription drugs, selection and use of consumer health products does not require the oversight of a health care practitioner.
Global Consumer Healthcare Drug market is projected to reach US$ 182520 million in 2029, increasing from US$ 125150 million in 2022, with the CAGR of 5.5% during the period of 2023 to 2029. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Consumer Healthcare Drug market research.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2029), aims to help readers to get a comprehensive understanding of global Consumer Healthcare Drug market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
By Company
Johnson & Johnson
AbbVie
Merck & Co.
GlaxoSmithKline
Pfizer
Sanofi
Takeda
Bayer
Teva
Sinopharm Group
CR Pharmaceutical
Shanghai Pharmaceuticals
Hualan Bio
North China Pharmaceutical
Hengrui Medicine
Fosun Pharma
East China Medicine
Livzon Group
Segment by Type
Solid Preparations
Oral Liquid
Patch
Other
Segment by Application
Hospital
Retail Pharmacy
Other
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
The Consumer Healthcare Drug report covers below items:
Chapter 1: Product Basic Information (Definition, Type and Application)
Chapter 2: Global market size, regional market size. Market Opportunities and Challenges
Chapter 3: Companies’ Competition Patterns
Chapter 4: Product Type Analysis
Chapter 5: Product Application Analysis
Chapter 6 to 10: Country Level Value Analysis
Chapter 11: Companies' Outline
Chapter 12: Market Conclusions
Chapter 13: Research Methodology and Data Source
Index1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Consumer Healthcare Drug Market Size Growth Rate by Type: 2018 VS 2022 VS 2029
1.2.2 Solid Preparations
1.2.3 Oral Liquid
1.2.4 Patch
1.2.5 Other
1.3 Market by Application
1.3.1 Global Consumer Healthcare Drug Market Growth by Application: 2018 VS 2022 VS 2029
1.3.2 Hospital
1.3.3 Retail Pharmacy
1.3.4 Other
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Consumer Healthcare Drug Market Perspective (2018-2029)
2.2 Consumer Healthcare Drug Growth Trends by Region
2.2.1 Global Consumer Healthcare Drug Market Size by Region: 2018 VS 2022 VS 2029
2.2.2 Consumer Healthcare Drug Historic Market Size by Region (2018-2023)
2.2.3 Consumer Healthcare Drug Forecasted Market Size by Region (2024-2029)
2.3 Consumer Healthcare Drug Market Dynamics
2.3.1 Consumer Healthcare Drug Industry Trends
2.3.2 Consumer Healthcare Drug Market Drivers
2.3.3 Consumer Healthcare Drug Market Challenges
2.3.4 Consumer Healthcare Drug Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Consumer Healthcare Drug Players by Revenue
3.1.1 Global Top Consumer Healthcare Drug Players by Revenue (2018-2023)
3.1.2 Global Consumer Healthcare Drug Revenue Market Share by Players (2018-2023)
3.2 Global Consumer Healthcare Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Consumer Healthcare Drug Revenue
3.4 Global Consumer Healthcare Drug Market Concentration Ratio
3.4.1 Global Consumer Healthcare Drug Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Consumer Healthcare Drug Revenue in 2022
3.5 Consumer Healthcare Drug Key Players Head office and Area Served
3.6 Key Players Consumer Healthcare Drug Product Solution and Service
3.7 Date of Enter into Consumer Healthcare Drug Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Consumer Healthcare Drug Breakdown Data by Type
4.1 Global Consumer Healthcare Drug Historic Market Size by Type (2018-2023)
4.2 Global Consumer Healthcare Drug Forecasted Market Size by Type (2024-2029)
5 Consumer Healthcare Drug Breakdown Data by Application
5.1 Global Consumer Healthcare Drug Historic Market Size by Application (2018-2023)
5.2 Global Consumer Healthcare Drug Forecasted Market Size by Application (2024-2029)
6 North America
6.1 North America Consumer Healthcare Drug Market Size (2018-2029)
6.2 North America Consumer Healthcare Drug Market Growth Rate by Country: 2018 VS 2022 VS 2029
6.3 North America Consumer Healthcare Drug Market Size by Country (2018-2023)
6.4 North America Consumer Healthcare Drug Market Size by Country (2024-2029)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Consumer Healthcare Drug Market Size (2018-2029)
7.2 Europe Consumer Healthcare Drug Market Growth Rate by Country: 2018 VS 2022 VS 2029
7.3 Europe Consumer Healthcare Drug Market Size by Country (2018-2023)
7.4 Europe Consumer Healthcare Drug Market Size by Country (2024-2029)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Consumer Healthcare Drug Market Size (2018-2029)
8.2 Asia-Pacific Consumer Healthcare Drug Market Growth Rate by Region: 2018 VS 2022 VS 2029
8.3 Asia-Pacific Consumer Healthcare Drug Market Size by Region (2018-2023)
8.4 Asia-Pacific Consumer Healthcare Drug Market Size by Region (2024-2029)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Consumer Healthcare Drug Market Size (2018-2029)
9.2 Latin America Consumer Healthcare Drug Market Growth Rate by Country: 2018 VS 2022 VS 2029
9.3 Latin America Consumer Healthcare Drug Market Size by Country (2018-2023)
9.4 Latin America Consumer Healthcare Drug Market Size by Country (2024-2029)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Consumer Healthcare Drug Market Size (2018-2029)
10.2 Middle East & Africa Consumer Healthcare Drug Market Growth Rate by Country: 2018 VS 2022 VS 2029
10.3 Middle East & Africa Consumer Healthcare Drug Market Size by Country (2018-2023)
10.4 Middle East & Africa Consumer Healthcare Drug Market Size by Country (2024-2029)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Johnson & Johnson
11.1.1 Johnson & Johnson Company Detail
11.1.2 Johnson & Johnson Business Overview
11.1.3 Johnson & Johnson Consumer Healthcare Drug Introduction
11.1.4 Johnson & Johnson Revenue in Consumer Healthcare Drug Business (2018-2023)
11.1.5 Johnson & Johnson Recent Development
11.2 AbbVie
11.2.1 AbbVie Company Detail
11.2.2 AbbVie Business Overview
11.2.3 AbbVie Consumer Healthcare Drug Introduction
11.2.4 AbbVie Revenue in Consumer Healthcare Drug Business (2018-2023)
11.2.5 AbbVie Recent Development
11.3 Merck & Co.
11.3.1 Merck & Co. Company Detail
11.3.2 Merck & Co. Business Overview
11.3.3 Merck & Co. Consumer Healthcare Drug Introduction
11.3.4 Merck & Co. Revenue in Consumer Healthcare Drug Business (2018-2023)
11.3.5 Merck & Co. Recent Development
11.4 GlaxoSmithKline
11.4.1 GlaxoSmithKline Company Detail
11.4.2 GlaxoSmithKline Business Overview
11.4.3 GlaxoSmithKline Consumer Healthcare Drug Introduction
11.4.4 GlaxoSmithKline Revenue in Consumer Healthcare Drug Business (2018-2023)
11.4.5 GlaxoSmithKline Recent Development
11.5 Pfizer
11.5.1 Pfizer Company Detail
11.5.2 Pfizer Business Overview
11.5.3 Pfizer Consumer Healthcare Drug Introduction
11.5.4 Pfizer Revenue in Consumer Healthcare Drug Business (2018-2023)
11.5.5 Pfizer Recent Development
11.6 Sanofi
11.6.1 Sanofi Company Detail
11.6.2 Sanofi Business Overview
11.6.3 Sanofi Consumer Healthcare Drug Introduction
11.6.4 Sanofi Revenue in Consumer Healthcare Drug Business (2018-2023)
11.6.5 Sanofi Recent Development
11.7 Takeda
11.7.1 Takeda Company Detail
11.7.2 Takeda Business Overview
11.7.3 Takeda Consumer Healthcare Drug Introduction
11.7.4 Takeda Revenue in Consumer Healthcare Drug Business (2018-2023)
11.7.5 Takeda Recent Development
11.8 Bayer
11.8.1 Bayer Company Detail
11.8.2 Bayer Business Overview
11.8.3 Bayer Consumer Healthcare Drug Introduction
11.8.4 Bayer Revenue in Consumer Healthcare Drug Business (2018-2023)
11.8.5 Bayer Recent Development
11.9 Teva
11.9.1 Teva Company Detail
11.9.2 Teva Business Overview
11.9.3 Teva Consumer Healthcare Drug Introduction
11.9.4 Teva Revenue in Consumer Healthcare Drug Business (2018-2023)
11.9.5 Teva Recent Development
11.10 Sinopharm Group
11.10.1 Sinopharm Group Company Detail
11.10.2 Sinopharm Group Business Overview
11.10.3 Sinopharm Group Consumer Healthcare Drug Introduction
11.10.4 Sinopharm Group Revenue in Consumer Healthcare Drug Business (2018-2023)
11.10.5 Sinopharm Group Recent Development
11.11 CR Pharmaceutical
11.11.1 CR Pharmaceutical Company Detail
11.11.2 CR Pharmaceutical Business Overview
11.11.3 CR Pharmaceutical Consumer Healthcare Drug Introduction
11.11.4 CR Pharmaceutical Revenue in Consumer Healthcare Drug Business (2018-2023)
11.11.5 CR Pharmaceutical Recent Development
11.12 Shanghai Pharmaceuticals
11.12.1 Shanghai Pharmaceuticals Company Detail
11.12.2 Shanghai Pharmaceuticals Business Overview
11.12.3 Shanghai Pharmaceuticals Consumer Healthcare Drug Introduction
11.12.4 Shanghai Pharmaceuticals Revenue in Consumer Healthcare Drug Business (2018-2023)
11.12.5 Shanghai Pharmaceuticals Recent Development
11.13 Hualan Bio
11.13.1 Hualan Bio Company Detail
11.13.2 Hualan Bio Business Overview
11.13.3 Hualan Bio Consumer Healthcare Drug Introduction
11.13.4 Hualan Bio Revenue in Consumer Healthcare Drug Business (2018-2023)
11.13.5 Hualan Bio Recent Development
11.14 North China Pharmaceutical
11.14.1 North China Pharmaceutical Company Detail
11.14.2 North China Pharmaceutical Business Overview
11.14.3 North China Pharmaceutical Consumer Healthcare Drug Introduction
11.14.4 North China Pharmaceutical Revenue in Consumer Healthcare Drug Business (2018-2023)
11.14.5 North China Pharmaceutical Recent Development
11.15 Hengrui Medicine
11.15.1 Hengrui Medicine Company Detail
11.15.2 Hengrui Medicine Business Overview
11.15.3 Hengrui Medicine Consumer Healthcare Drug Introduction
11.15.4 Hengrui Medicine Revenue in Consumer Healthcare Drug Business (2018-2023)
11.15.5 Hengrui Medicine Recent Development
11.16 Fosun Pharma
11.16.1 Fosun Pharma Company Detail
11.16.2 Fosun Pharma Business Overview
11.16.3 Fosun Pharma Consumer Healthcare Drug Introduction
11.16.4 Fosun Pharma Revenue in Consumer Healthcare Drug Business (2018-2023)
11.16.5 Fosun Pharma Recent Development
11.17 East China Medicine
11.17.1 East China Medicine Company Detail
11.17.2 East China Medicine Business Overview
11.17.3 East China Medicine Consumer Healthcare Drug Introduction
11.17.4 East China Medicine Revenue in Consumer Healthcare Drug Business (2018-2023)
11.17.5 East China Medicine Recent Development
11.18 Livzon Group
11.18.1 Livzon Group Company Detail
11.18.2 Livzon Group Business Overview
11.18.3 Livzon Group Consumer Healthcare Drug Introduction
11.18.4 Livzon Group Revenue in Consumer Healthcare Drug Business (2018-2023)
11.18.5 Livzon Group Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
